[Significance of clinical tests in collagen diseases (discussion)].
Miyasaka
Nobuyuki
N
Shimizu
Masatoshi
M
Yoshida
Shoji
S
Hirakata
Michito
M
Ochi
Sae
S
D000974:Antibodies, Antinuclear / Q000032:analysis; D017152:Antibodies, Antiphospholipid / Q000032:analysis; D000941:Antigens / Q000097:blood; D000951:Antigens, Neoplasm; D001172:Arthritis, Rheumatoid / Q000175:diagnosis; D001323:Autoantibodies / Q000032:analysis; D015415:Biomarkers; D001799:Blood Sedimentation; D002097:C-Reactive Protein / Q000032:analysis; D003095:Collagen Diseases / Q000145:classification / Q000175:diagnosis*; D016207:Cytokines / Q000032:analysis; D005293:Ferritins / Q000097:blood; D006023:Glycoproteins / Q000097:blood; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis; D018396:Mucin-1; D009077:Mucins; D018121:Receptors, Cytokine / Q000032:analysis; D012217:Rheumatoid Factor / Q000032:analysis
D000974:Antibodies, Antinuclear; D017152:Antibodies, Antiphospholipid; D000941:Antigens; D000951:Antigens, Neoplasm; D001323:Autoantibodies; D015415:Biomarkers; D016207:Cytokines; D006023:Glycoproteins; C060192:MUC1 protein, human; D018396:Mucin-1; D009077:Mucins; D018121:Receptors, Cytokine; D002097:C-Reactive Protein; D005293:Ferritins; D012217:Rheumatoid Factor